Related by context. All words. (Click for frequent words.) 65 Determinants 65 Correlates 64 Main Outcome Measures 63 Comorbidities 63 Depressive Symptoms 61 Comorbid 61 Meta Analysis 61 Main Outcome Measure 60 predictors 59 Functional Outcomes 59 Comorbidity 58 Randomized Controlled Trials 58 Hemodialysis Patients 58 Asymptomatic 58 Diagnostic Criteria 58 CONCLUSIONS 58 Clinical Outcome 58 multivariate analyzes 58 Prevalence 58 Randomized Controlled Trial 57 Patients Undergoing 57 Controlled Trial 57 Postoperative 57 Postmenopausal Women 57 Psychiatric Disorders 57 Symptom Severity 57 Elderly Patients 57 Subtypes 57 Orthostatic Hypotension 57 Patients Treated 57 Radical Prostatectomy 57 univariate analysis 57 Patients Receiving 57 Gene Linked 57 syndromal 57 comorbid depression 56 Improves Outcomes 56 Cognitive Function 56 Adjuvant Therapy 56 Generalized Anxiety Disorder 56 Systematic Review 56 Statin Therapy 56 Differential Diagnosis 56 Respiratory Symptoms 56 Suicidal Ideation 56 Depression Anxiety 56 Effective Treatments 56 subscale scores 56 Adjuvant Chemotherapy 56 Pediatric Patients 56 Appears Safe 56 Study Demonstrates 56 affective disorders 56 Left Ventricular Hypertrophy 56 univariate analyzes 55 polyarticular 55 Coronary Artery Bypass Surgery 55 Symptom 55 Pharmacologic 55 Rheumatoid Arthritis Patients 55 Ischemic Stroke 55 subscales 55 comorbid anxiety 55 Gene Variants 55 Intervention Trial 55 Heart Failure Patients 55 Increases Risk 55 Predict Response 55 Liver Failure 55 Preoperative 55 Malignancies 55 Data Suggest 55 Recurrence 55 Conclusions 55 Inhaled Corticosteroids 55 Cardiovascular Events 55 Panic Disorder 55 Neurocognitive 55 ST Segment Elevation 55 Lipid Levels 55 Etiology 55 Prognostic Factors 55 Smoking Linked 55 Montgomery Åsberg Depression 54 Prefrontal 54 Cardiovascular Risk Factors 54 Anxiety Depression 54 Prognostic 54 Controlled Study 54 Septic Shock 54 Long Term Outcomes 54 interobserver 54 Pathologic 54 Proves Effective 54 Cognitive Impairment 54 Hamilton Rating Scale 54 Health Assessment Questionnaire 54 Predict Risk 54 comorbidity 54 Psychological Distress 54 Increased Risk 54 Risk Stratification 54 Fracture Risk 54 Prophylactic Treatment 54 Depressive symptoms 54 Increased Mortality 54 Levels Linked 54 Relapsing Multiple Sclerosis 54 Node Positive 54 multivariable analysis 54 Angiographic 54 Predisposition 54 Randomized Trials 54 Localized Prostate Cancer 54 RENAL 54 covariate 54 HRQL 54 Correlation Between 54 Venous Thromboembolism 54 Social Phobia 54 Infarction 54 Primary endpoints 54 Rating Scale MADRS 54 Cognitive Functioning 54 Sleep Disturbance 54 Gene Mutation 54 Invasive Breast Cancer 54 comorbid disorders 54 Lowers Risk 54 Antibiotic Therapy 54 Posttraumatic 54 Postprandial 54 Study Identifies 54 Premenopausal Women 54 hemodynamically significant 54 Gender Differences 54 Well Tolerated 53 Overactive Bladder 53 Patients Treated With 53 psychiatric outpatients 53 Genetic Markers 53 Study Examines 53 logistic regression model 53 Cardiac Resynchronization 53 Carcinomas 53 Clinical Efficacy 53 Obesity Linked 53 strongest predictor 53 Subgroup Analysis 53 Sociodemographic 53 Treatment Outcome 53 Cardiogenic Shock 53 Statistically Significant 53 familial aggregation 53 Suicidal Behavior 53 BMI z 53 Pain Intensity 53 Newly Diagnosed Multiple Myeloma 53 Kidney Transplants 53 carotid intima media 53 Endocrine Therapy 53 Immunosuppression 53 Randomized Study 53 Pain Rating Scale 53 Infected Patients 53 Fecal Incontinence 53 Histological 53 Mouse Model 53 Subscale 53 alexithymia 53 Improves Survival 53 Brief Psychiatric 53 Chronic Hepatitis C 53 Tolerability 53 Stent Implantation 53 Posttraumatic stress disorder 53 Abnormality 53 Relapsing Remitting Multiple Sclerosis 53 Pooled Analysis 53 Prognostic significance 53 Cognitive Decline 53 Short Stature 53 Coronary Artery Calcium 53 psychiatric comorbidity 53 Knee Osteoarthritis 53 Anti Tumor Activity 53 Combination Treatment 53 psychiatric morbidity 53 Genes Discovered 53 Intracranial 53 autonomic dysfunction 53 Nemeroff CB 53 Premature Infants 53 multivariate Cox 53 Gene Variant 53 Sonographic 53 Psychiatric Illness 53 Thrombotic 53 Shows Efficacy 53 strongest predictors 53 Gene Mutations 53 Genes Linked 53 euthymic patients 53 Treating Chronic 53 Ischemic Heart Disease 53 Histologic 53 Iron Deficiency 52 Clinical Relevance 52 Prostatic 52 Induction Therapy 52 Univariate analysis 52 Study Shows Significant 52 Breast Cancers 52 Chronic Insomnia 52 Can Predict 52 Pharmacokinetic Study 52 chronicity 52 Hormone Receptor Positive 52 Subclinical 52 Hypertensive Patients 52 Symptom Checklist 52 Improve Survival 52 Antidepressants Linked 52 Plus Ribavirin 52 psychosocial functioning 52 Survival Benefit 52 depressive symptomatology 52 Prognostic Significance 52 Pregnancy Linked 52 Patient Populations 52 Lymph Nodes 52 affective psychosis 52 Ischemic 52 Who Underwent 52 Clinical Significance 52 microsatellite instability 52 Framingham Offspring 52 Breast Cancer Recurrence 52 Dose Response 52 Chronic Heart Failure 52 Long Term Efficacy 52 covariates 52 Laryngeal Cancer 52 Clostridium difficile Infection 52 Prostate Cancer Recurrence 52 Cardiovascular Outcomes 52 leiomyomas 52 Test Detects 52 Obese Patients 52 Reduces Mortality 52 Left Ventricular 52 neurocognitive impairment 52 meta analytic review 52 Helps Relieve 52 Lesion 52 Prostatectomy 52 Induces 52 Pharmacokinetic 52 Inhibits 52 comorbid 52 Non Responders 52 comorbid psychiatric disorders 52 Aggressive Prostate Cancer 52 Mortality Risk 52 Acute Myocardial Infarction 52 Recurrent Stroke 52 Preterm Infants 52 Metastatic Prostate Cancer 52 Help Predict 52 Myocardial Infarction 52 Therapy Shows Promise 52 univariate 52 Epoetin Alfa 52 Viral Suppression 52 Physical Function 52 Outcome Measures 52 Disease Progression 52 Uterine 52 Infarct 52 Negative Symptoms 52 Beta Amyloid 52 Demonstrates Positive 52 Treatment Resistant 52 Symptom Scale 52 posttreatment 52 Genetic Tests 52 multivariate adjustment 52 subscore 52 logistic regression 52 Researchers Uncover 52 Sleep Duration 52 Breast Carcinoma 52 Metastatic Renal Cell Carcinoma 52 Idiopathic 52 Bone Metastases 52 Blocked Arteries 52 Treatment Naive HIV 52 Multicenter Study 52 Diabetic Patients 52 Body Dysmorphic Disorder 52 COPERNICUS 52 emotional lability 52 Atrial 51 Kidney Function 51 Adult Onset 51 Thrombolysis 51 bivariate analyzes 51 Stress Induced 51 Blood Pressure Drugs 51 Tumor Cell 51 Univariate 51 Posttraumatic Stress 51 Complication Rates 51 Carotid Stenting 51 Scale Revised 51 Clinical Trial Results 51 untreated psychosis 51 Prolonged Survival 51 Demonstrates Efficacy 51 HAM D# 51 Randomized Clinical Trial 51 Could Predict 51 Monotherapy 51 Stroke Risk 51 Survival Rates 51 Survey Findings 51 Heterogeneity 51 Cholesterol Levels 51 Exacerbation 51 Hemolysis 51 Allogeneic 51 Slow Progression 51 Often Misdiagnosed 51 Major Depressive 51 Severity Index 51 Abdominal Fat 51 Inflammatory Pain 51 Dissociation 51 multivariable adjusted 51 Antipsychotic Drugs 51 ACER paper 51 Prognostic Value 51 Assessment Scale 51 Neuropsychological 51 SF #v# 51 Visual Analog Scale 51 Antibiotic Treatment 51 HER2 Positive Breast Cancer 51 Chronic Renal Failure 51 psychometric properties 51 Peginterferon Alfa 2a 51 Secondary endpoints included 51 Heritability 51 Myocardial Ischemia 51 Sustained Virologic Response 51 Drug Shows Promise 51 Glycemic Control 51 Intracerebral Hemorrhage 51 Study Uncovers 51 Contrast Agents 51 headache abdominal pain 51 Neuroticism 51 TP# mutations 51 Study Sheds Light 51 Exclusion criteria 51 et al #a 51 posttransplant 51 Cognitive Deficits 51 symptomatology 51 Histopathologic 51 Treatment Naive 51 Stable Angina 51 Partial Onset Seizures 51 Randomized Double Blind 51 Reduced Risk 51 Demonstrates Significant 51 Reduces Risk 51 sociodemographic characteristics 51 Study Evaluating 51 gene polymorphisms 51 Primary Endpoint 51 Physician Insights 51 et al #b 51 Antipsychotic Medications 51 Significantly Reduced 51 HADS 51 Renal Function 51 premorbid 51 Antidepressant Treatment 51 Tumor Progression 51 Predict Prostate Cancer 51 Cytogenetic 51 Therapy Improves 51 polyposis 51 Bone Mineral Density 51 Renal Artery 51 unipolar depression 51 regression analyzes 51 Breast Tumors 51 Rating Scale 51 Depression Inventory 51 multivariate analysis 51 QoL 51 Significantly Reduces 51 Effectively Treats 51 Emerging Therapies 51 Hemodynamic 51 nonfatal MI 51 Symptom Improvement 51 Study Suggests 51 Patency 51 Prostate Biopsy 51 impaired glucose metabolism 51 Impairs 51 Adiposity 51 Oral Fingolimod 51 PSA kinetics 50 Treatment Reduces 50 Chronic Sinusitis 50 Prolongs Life 50 Gunderson JG 50 Socioeconomic Status 50 Randomized Evaluation 50 longitudinal studies 50 Sexual Desire 50 Predictive Value 50 Malformations 50 somatic symptoms 50 Myocardial 50 lowest tertile 50 Rating Scale BPRS 50 subsyndromal 50 Multiple Myeloma Patients 50 Key Attributes 50 Neoplasms 50 Gastric Ulcers 50 Acute Kidney 50 Study Indicates 50 Venous Thrombosis 50 Brain Atrophy 50 Hypertrophy 50 prespecified secondary 50 Virus Linked 50 Hepatic 50 Solid Tumors 50 #-# Full Text 50 inversely associated 50 Sexual Function 50 Orally Active 50 Castration Resistant Prostate Cancer 50 Hippocampal 50 Sleep Disturbances 50 Susceptibility 50 Chronic Pelvic Pain 50 Adverse Event 50 Improve Outcomes 50 Transurethral 50 Genes Associated 50 Treatment Diabetic Retinopathy 50 Osteoporosis Drugs 50 susceptibility locus 50 SCr 50 Adenoma 50 poststroke 50 CORE OM 50 Recurrent Breast Cancer 50 EQ 5D 50 Genes Identified 50 Insulin Sensitivity 50 Myocardial Perfusion 50 PSQI 50 Resulted 50 Hepatitis C Genotype 50 Treating Depression 50 Myeloid 50 hypogonadotropic hypogonadism 50 Strongly Linked 50 Sipuleucel T 50 Brain Metastases 50 Birth Weight 50 Ethnic Differences 50 Subtype 50 cerebral microbleeds 50 depressive symptoms 50 Node Negative 50 Brain Scans 50 Study Casts Doubt 50 Carotid Endarterectomy 50 Patellofemoral 50 Elevated Levels 50 Help Detect 50 #:#-# [023] 50 Acute Coronary Syndromes 50 Placebo Controlled Study 50 Prospective Randomized 50 prognostic significance 50 histologically proven 50 Less Likely 50 Histopathological 50 Renal Cell Carcinoma 50 II Clinical Trial 50 multivariable Cox 50 Antihypertensive 50 Ventricular 50 Drug Candidate 50 International Prostate Symptom 50 Acute Coronary 50 Abnormal Involuntary Movement 50 Advanced Melanoma 50 Valvular 50 comorbidities 50 Life Threatening 50 HRQOL 50 Preclinical Study 50 tertiles 50 Microalbuminuria 50 Coronary Syndromes 50 Androgen Deprivation Therapy 50 Complicated Grief 50 Long Term Survival 50 Pegylated Liposomal Doxorubicin 50 vesicoureteral reflux 50 Kendler KS 50 HRQoL 50 Gene Variation 50 Assessment Questionnaire 50 Cancer Recurrence 50 STRATEGY FOR AN OPEN 50 schizophrenia schizoaffective disorder 50 confounder 50 Acute Pancreatitis 50 Novel Inhibitor 50 #q# deletion syndrome 50 Drug Combo 50 Tumor Response 50 Genetic Variants 50 Clinical Trial Data 50 Atherosclerotic 50 Antidepressant Use 50 Surgical Treatment 50 Radiofrequency Ablation 50 Hormone Therapy 50 Menopausal Women 50 Unfractionated Heparin 50 Stent Thrombosis 50 Colorectal Cancer Patients 50 virological response 50 Critically Ill Patients 50 Shows Promise Against 50 Stent Restenosis 50 Antipsychotic 50 subtrochanteric 50 Follicular Lymphoma 50 Skin Lesions 50 Novel Treatments 50 Brain Function 50 Chemotherapy Induced 50 exploratory endpoints 50 Significantly Improved 50 neurocognitive deficits 50 Endothelium 50 echocardiographic parameters 50 Radiation Induced 50 antiphospholipid antibodies 50 Hyperlipidemia 50 headache nasopharyngitis 50 Dyspnea 50 suicide attempters 50 Autologous Stem Cell Transplantation 50 Calcification 50 Estrogen Therapy 50 Osteoarthritis Patients 50 Reduce Mortality 50 Likelihood 50 Exposure Linked 50 Chemoradiation 50 Cognitive Dysfunction 50 Pharmacokinetics PK 50 Adjuvant Treatment 50 highest tertile 50 subscores 50 Beta Blockers 50 Evoked 50 Geriatric Depression 50 Unstable Angina 50 underwent resection 50 transient elastography 49 preoperative diagnosis 49 Tumor Cells 49 drug eluting stent implantation 49 Sirolimus Eluting Stent 49 multiple logistic regression 49 prognostic factor 49 Eye Diseases 49 histological subtype 49 rCBF 49 comorbid conditions 49 bivariate 49 Psychodynamic 49 Phase III Pivotal Trial 49 Urine Test 49 Combination Clinical Trial 49 More Susceptible 49 nasopharyngitis headache 49 MMSE score 49 Bare Metal Stents 49 Disease Modification 49 cerebral perfusion 49 Adverse Effects 49 Antecedents 49 Pharmacodynamics 49 Treatment Regimens 49 Hormone Refractory Prostate Cancer 49 #F FDG PET 49 Colorectal Adenomas 49 Neoadjuvant Chemotherapy 49 esophageal carcinoma 49 Antipsychotic Drug 49 depression schizophrenia bipolar 49 Ultrasonographic 49 Total Knee Arthroplasty 49 Glucose Levels 49 QIDS SR 49 Hepatic Impairment 49 Aggressive Reduction 49 Breast Tissue 49 Colorectal Cancers 49 Montgomery Asberg Depression 49 Postmenopausal 49 Patients Suffering 49 Dual Antiplatelet Therapy 49 Shows Promising 49 Helicobacter pylori eradication 49 Attitudes Toward 49 multivariate logistic regression 49 Obsessive Compulsive 49 Cholesterol Levels SPARCL 49 hyperacute 49 Metastases 49 Combo Therapy 49 Boosts Survival 49 Drug Prevents 49 Seasonal Pattern 49 psychosocial variables 49 logistic regression analyzes 49 carotid IMT 49 prospectively defined 49 J Clin Oncol 49 Binge Eating 49 Lung Cancer Risk 49 clinicopathologic 49 Vitamin D Linked 49 Psychological Stress 49 Anti Tumor 49 intima media thickness IMT 49 Prospective Randomized Trial 49 Protein Linked 49 IL#B 49 Treated Patients 49 Potentially Fatal 49 aspartate aminotransferase AST 49 Previously Treated 49 GH deficiency 49 Myocardial Infarction Study 49 Endometrial Cancer 49 Ejection Fraction 49 P = .# 49 Genetic Variations 49 Peripheral Arterial 49 Coronary Arteries 49 preoperative PSA 49 sociodemographic variables 49 serum estradiol 49 serum cortisol 49 predisposing factor 49 Severe Sepsis 49 Study Validates 49 Efficacy 49 #:#-# [031] 49 Insulin Resistance 49 Cardiac Function 49 MR Angiography 49 HER2 expression 49 cortical thinning 49 MetS 49 Chronic Constipation 49 Virologic 49 logistic regression analysis 49 Nicotine Addiction 49 Chronic HCV 49 carotid atherosclerosis 49 postoperative AF 49 Demonstrated Significant 49 False Positive 49 Intracranial Aneurysms 49 Chemotherapeutic Agents 49 Polymorphism 49 Periodontal Disease 49 nulliparous women 49 Excessive Sleepiness 49 Testosterone Levels 49 Immunologic 49 Clinical Outcomes 49 Zoledronic Acid 49 Contralateral 49 Modulates 49 CT Angiography 49 Mitral Regurgitation 49 Study Explores 49 Hip Fracture 49 Data Indicate 49 Placebo Controlled Trial 49 Inhaled Steroids 49 Thromboembolism 49 Immune Responses 49 Respiratory Problems 49 Hormone Levels 49 liver transplant recipients 49 hallux valgus 49 DAS# scores 49 Contraceptive Use 49 Urogenital 49 Sexual Satisfaction 49 Unresectable 49 Cancer Diagnosis 49 Antitumor Activity 49 rs# [004] 49 abdominal adiposity 49 Deep Venous Thrombosis 49 Peginterferon Alfa 2b 49 Atypical Hemolytic Uremic Syndrome 49 prognostic factors 49 Psychotic Disorders 49 Versus Placebo 49 venous thromboembolic disease 49 BERKELEY CA UroToday.com 49 Score DAS 49 Outcomes Study 49 Subgroup analysis 49 Atopic Dermatitis 49 Manifestations 49 Colon Polyps 49 Is Well Tolerated 49 Disease Modifying 49 Study Confirms 49 Discrepancy 49 meta regression 49 tumor necrosis 49 Multicenter 49 #:#-#,# CrossRef Medline [002] 49 ORLive Presents 49 Stem Cell Transplants 49 elevated transaminases 49 plasma cortisol 49 pain catastrophizing 49 Neuroprotective Effects 49 Benign Prostatic Hyperplasia 49 Nephropathy 49 Prospective Multicenter 49 Clinical Trial Evaluating 49 primary aldosteronism 49 Antiviral Therapy 49 = #.#-#.# 49 Kaplan Meier analysis 49 Usefulness 49 MMSE 49 carotid artery intima media 49 Tumor Growth 49 Androgen 49 Diabetic Foot Ulcer 49 Preterm Delivery 49 sonographic findings 49 Poorly Controlled 49 Carotid 49 Researchers Identify 49 Lymph Node 49 Y BOCS 48 Disease Severity 48 Lung Injury 48 Neuroprotection 48 Stable Coronary Artery 48 Cardiovascular Risk 48 Negative Effects 48 Platelet Inhibition 48 atopic asthma 48 subclinical atherosclerosis 48 Alzheimer Disease Assessment 48 Predict Dementia 48 Scale PANSS 48 Ventricular Tachycardia 48 left ventricular LV 48 Polymorphisms 48 Hospitalized Patients 48 Helps Diagnose 48 neuropsychological deficits 48 Gastric Bypass Surgery 48 Prostate Cancer Patients 48 ventricular hypertrophy 48 Symptom Relief 48 Genotypes 48 retest reliability 48 Beta Blocker 48 Stressors 48 Epworth Sleepiness Scale 48 Resection 48 colorectal adenoma 48 Contraindications 48 Aromatase Inhibitors 48 Breast Cancer Treatment 48 Tasigna prolongs 48 Thrombus 48 β = 48 â ‰ ¥ 48 Genetic Variation 48 intraclass correlation coefficients 48 Author Addresses 48 Prophylaxis 48 Response Evaluation Criteria 48 Improved Survival 48 Relationship Between 48 bladder carcinoma 48 etiologic factors 48 Cause Mortality 48 Mouse Models 48 Study Proves 48 Coronary Artery Bypass Graft 48 Help Diagnose 48 Cardiotoxicity 48 Correlated 48 Non Alcoholic Fatty 48 Circulating Tumor Cells 48 Cognitive Problems 48 Prostate Cancer Progression 48 Endothelial Function 48 electroencephalographic 48 Hormone Replacement 48 BACKGROUND AND 48 Correlations 48 subanalysis 48 Severity 48 Juvenile Idiopathic Arthritis 48 interrater reliability 48 Sex Hormones 48 Cortical 48 meta analytic 48 Could Prevent 48 Statin Drugs 48 proband 48 adenotonsillectomy 48 Study Analyzes 48 hemodynamic measurements 48 Relapsed Multiple Myeloma 48 HIV HCV coinfected 48 Gastrointestinal Disorders 48 Blood Pressure Reduction 48 Progenitor Cells 48 hypertension diabetes mellitus 48 urothelial carcinoma 48 Atypical Antipsychotics 48 NSTEMI 48 Restless Legs 48 Acute Ischemic Stroke 48 Nonalcoholic Fatty Liver Disease 48 Early Diagnosis 48 Abciximab 48 Clinician Administered PTSD 48 Functional Assessment 48 Incontinence Impact Questionnaire 48 Eds. 48 Cocaine Addiction 48 atherosclerotic renal artery stenosis 48 neuroimaging studies 48 covariance ANCOVA 48 Reduces Pain 48 Insufficiency 48 adrenocortical 48 aminotransferase 48 Study Compares 48 Arch Neurol 48 Induced 48 Skeletal Muscle 48 depressive symptom 48 Diagnosis 48 Stress Hormone 48 Antitumor 48 left ventricular diastolic 48 T1DM 48 Leg Ulcers 48 See CLINICAL PHARMACOLOGY 48 antenatal depression 48 Intervention Effectiveness CATIE 48 Impair 48 Osteotomy 48 renal cysts 48 plasma pharmacokinetics 48 Prevent Heart 48 Behavior Problems 48 Diagnosis Treatment 48 Prolongs Survival 48 inhibin B 48 Phase IIb Trial 48 Device Helps 48 Suicidality 48 Showed Significant 48 Childhood Trauma 48 diffusion weighted 48 Coronary Angiography 48 Alcohol Consumption 48 Mammographic 48 Outpatient Setting 48 Protease Inhibitors 48 prospective longitudinal 48 Liver Injury 48 DCE MRI 48 Abdominal Pain 48 LVSD 48 Distal 48 Advanced Colorectal Cancer 48 Cystatin C 48 promoter polymorphism 48 intraobserver 48 Double Blind Randomized 48 biochemical relapse 48 cerebral infarctions 48 Pharmacodynamic 48 Acute Physiology 48 F FDG PET 48 Cervical Spine 48 morphometric 48 Colorectal Cancer Risk 48 Investigational Agent 48 Therapeutic Efficacy 48 Electrophysiological 48 thickness IMT 48 % CI #.#-#.# [006] 48 Estrogen Receptor 48 Study ETDRS 48 Endpoints 48 Hepatotoxicity 48 thyrotropin levels 48 Ureteral 48 Hormonal Therapy 48 Premature Death 48 SYMPTOMS 48 Often Overlooked 48 Suboptimal 48 WOMAC pain 48 IBDQ 48 FDA Approves Drug 48 Pelvic Organ Prolapse 48 subthreshold depression 48 Immunohistochemical 48 Secondary endpoints 48 JAK Inhibitor 48 Neuropsychiatric Inventory 48 Exacerbations 48 Biological Basis 48 nonobese 48 predictor 48 tHcy 48 Mental Status 48 Peritoneal 48 prepubertal 48 Randomized Placebo Controlled Trial 48 Tiotropium 48 Viral Load 48 Surgical Procedures 48 Partial Response 48 Randomized Controlled 48 Neuropsychiatric Inventory NPI 48 Relieve Depression 48 Proliferative 48 Fewer Side Effects 48 hypovitaminosis D 48 Neuropathic 48 substudy 48 correlated inversely 48 ADCS CGIC 48 Predict Breast Cancer 48 paresthesias 48 #:#-# [037] 48 Index CDAI 48 Capsular 48 Catheter Ablation 48 Detecting Breast Cancer 47 Symptom severity 47 Inflammatory Markers 47 Phase 2b Study 47 Vertebral Fractures 47 Tests Reveal 47 Visual Analog 47 Studies Suggest 47 rheumatoid factor 47 prospective cohort 47 JA et al 47 State Trait Anxiety 47 Genetic Mutation 47 Aggressive Behavior 47 confidence intervals CIs